Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) .
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 53.00 | |
2 mg | In stock | $ 75.00 | |
5 mg | In stock | $ 123.00 | |
10 mg | In stock | $ 197.00 | |
25 mg | In stock | $ 349.00 | |
50 mg | In stock | $ 539.00 | |
100 mg | In stock | $ 697.00 | |
200 mg | In stock | $ 995.00 | |
500 mg | In stock | $ 1,490.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 136.00 |
Description | PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) . |
In vitro | PF-07321332 is a promising oral antiviral clinical candidate with well-established anti-SARS-CoV-2 activity in vitro. |
Molecular Weight | 499.53 |
Formula | C23H32F3N5O4 |
CAS No. | 2628280-40-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 130 mg/mL (260.24 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nirmatrelvir 2628280-40-8 Microbiology/Virology SARS-CoV PF 07321332 inhibit Antiviral virus Inhibitor PF07321332 PF-07321332 SARS coronavirus HIV 3CLPRO inhibitor